.025 semaglutide OZEMPIC (SEMAGLUTIDE) 0.25MG INJ 1`S (NL) Prescription Weight Loss with Semaglutide

Among participants 4 to 66 years of age with acquired hypothalamic obesity, setmelanotide, a melanocortin-4 receptor agonist, led to significantly greater reductions in body-mass index and hunger...

Both have shown promising results, but they operate differently and offer distinct benefits

[USA] GLPs JDC Burst 1 has received the Parnelli Award for Indispensable Technology [...]

Dr Reddys launches oral semaglutide biosimilar tablets, offering broader access to diabetes and weight-loss therapies in India.

Task force members report early experience across three distinct cases of locally advanced CRC in patients with severe obesity, demonstrating successful preoperative visceral fat reduction through multidisciplinary coordination incorporating metabolic bariatric surgery or pharmacologic therapy during neoadjuvant windows, followed by definitive oncologic resection